Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20190525043700N5
IRCT20190525043700N5
Recruiting
Phase 3

Comparison of the effectiveness of Escitalopram and Bupropion in treatment of depression symptome patient with heart failure in double blind randomized clinical trial

Babol University of Medical Sciences0 sites80 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDepression.Major depressive disorder, single episode, mildF32.0

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Depression.
Sponsor
Babol University of Medical Sciences
Enrollment
80
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age over 18 years old
  • •With heart failure
  • •Depressive Disorder (Based on the questionnaire)
  • •Willingness to participate in the study

Exclusion Criteria

  • •Patient with cognitive impairment
  • •Mental retardation
  • •History of substance use
  • •Bipolar disorder
  • •History of depression before heart failure
  • •History of seizure

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11
IRCT20211208053331N1Ahvaz University of Medical Sciences172
Completed
Not Applicable
Efficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trialmajor depressive disorder
JPRN-UMIN000011191Department of Psychiatry, Fujita Health University School of Medicine200
Suspended
Not Applicable
The head-to-head comparison between escitalopram and mirtazapine for anxiety and agitation on the patients with depression, especially for the efficacy and safety.depression
JPRN-UMIN000014609europsychiatry dept., Osaka Medical College80
Completed
Phase 4
Comparison Of Two Anti Depressant Drugs In Major Depressive DisorderHealth Condition 1: null- Major Depressive Disorder
CTRI/2018/02/011662Government Medical College50
Recruiting
Phase 2
Efficacy of Escitalopram, Venlafaxine and Buspirone in Irritable Bowel SyndromeIrritable bowel syndrome.Irritable bowel syndrome
IRCT20150630022991N10Babol University of Medical Sciences90